170 related articles for article (PubMed ID: 24367489)
1. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.
Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC
PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489
[TBL] [Abstract][Full Text] [Related]
2. Urinary cytidine as an adjunct biomarker to improve the diagnostic ratio for gastric cancer in Taiwanese patients.
Lo WY; Jeng LB; Lai CC; Tsai FJ; Lin CT; Chen WT
Clin Chim Acta; 2014 Jan; 428():57-62. PubMed ID: 24177150
[TBL] [Abstract][Full Text] [Related]
3. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
[TBL] [Abstract][Full Text] [Related]
4. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer prognostic significance of some modified urinary nucleosides.
Sasco AJ; Rey F; Reynaud C; Bobin JY; Clavel M; Niveleau A
Cancer Lett; 1996 Nov; 108(2):157-62. PubMed ID: 8973589
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
[TBL] [Abstract][Full Text] [Related]
7. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
8. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
[TBL] [Abstract][Full Text] [Related]
10. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
12. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
Seidel A; Seidel P; Manuwald O; Herbarth O
Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
[TBL] [Abstract][Full Text] [Related]
13. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
14. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
[TBL] [Abstract][Full Text] [Related]
15. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
17. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
[TBL] [Abstract][Full Text] [Related]
18. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of six modified nucleosides by patients with breast carcinoma.
Vreken P; Tavenier P
Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():598-603. PubMed ID: 3426126
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
